SCHEMBL4255987

SCHEMBL4255987

Cc1cn(-c2ccc(NC(=O)NS)cc2F)cn1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 8/20 0.45
PSEN2 P49810 8/20 0.45
APH1B Q8WW43 8/20 0.45
NCSTN Q92542 8/20 0.45
APH1A Q96BI3 8/20 0.45
PSENEN Q9NZ42 8/20 0.45
USP30 Q70CQ3 1/20 0.43
KCNH2 Q12809 1/20 0.42
GPR142 Q7Z601 1/20 0.42
BLM P54132 1/20 0.41
PTK2 Q05397 1/20 0.41
NR2E1 Q9Y466 2/20 0.40
KCNJ6 P48051 3/20 0.38
KCNJ5 P48544 3/20 0.38
KCNJ3 P48549 3/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
QPCT Q16769 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1077292 0.82 PSEN1 (0.43) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1076567 0.81 PSEN1 (0.48) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1617435 0.80 PSEN1 (0.45) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1450033 0.79 PTK2 (0.56) GPR142PTK2NR2E1NPC1RAB9A
SCHEMBL14036806 0.77 PSEN1 (0.47) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL10072619 0.77 USP30 (0.53) PSEN1PSEN2APH1BNCSTNAPH1A
Nitric Acid SCHEMBL1617470 0.76 PSEN1 (0.41) PSEN1PSEN2APH1BNCSTNAPH1A
Nitric Acid SCHEMBL1617372 0.76 PSEN1 (0.41) PSEN1PSEN2APH1BNCSTNAPH1A
Nitric Acid SCHEMBL1617375 0.76 PSEN1 (0.41) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5235675 0.76 PTGDR2 (0.51) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012030952-A3 REDUCING RIPPLE CURRENT IN A SWITCHED-MODE POWER CONVERTER EMPLOYING A BRIDGE TOPOLOGY TEXAS INSTRUMENTS INCORPORATED (US) 2012-05-10 WO disclosed
US-20090181965-A1 MODULATORS FOR AMYLOID BETA F. HOFFMANN-LA ROCHE AG (CH) 2009-07-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181965-A1 MODULATORS FOR AMYLOID BETA APP, PSEN1, BACE1 PSEN1 2/4885PSEN2 6/4885APH1B 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.